Effects of liraglutide on cardiovascular outcomes in patients with diabetes with or without heart failure

SP Marso, FMM Baeres, SC Bain, B Goldman… - Journal of the American …, 2020 - jacc.org
Background More data regarding effects of glucagon-like peptide-1 receptor agonists in
patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives The …

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.

SP Marso, FMM Baeres, SC Bain… - Journal of the …, 2020 - europepmc.org
Background More data regarding effects of glucagon-like peptide-1 receptor agonists in
patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives The …

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure

SP Marso, FMM Baeres, SC Bain, B Goldman… - 2020 - pubmed.ncbi.nlm.nih.gov
Background More data regarding effects of glucagon-like peptide-1 receptor agonists in
patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives The …

[HTML][HTML] Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure

SP Marso, FMM Baeres, SC Bain, B Goldman… - Journal of the American …, 2020 - Elsevier
Background More data regarding effects of glucagon-like peptide-1 receptor agonists in
patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives The …

[PDF][PDF] Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure

SP Marso, FMM Baeres, SC Bain, B Goldman… - scholar.archive.org
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or
Without Heart Failure Page 1 Effects of Liraglutide on Cardiovascular Outcomes in Patients …

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure

LEADER Trial Investigators - Journal of the …, 2020 - utsouthwestern.elsevierpure.com
Background: More data regarding effects of glucagon-like peptide-1 receptor agonists in
patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives: The …

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure

SP Marso, FMM Baeres, SC Bain… - Journal of the …, 2020 - cdr.lib.unc.edu
Background: More data regarding effects of glucagon-like peptide-1 receptor agonists in
patients with type 2 diabetes (T2D) and heart failure (HF) are required. Objectives: The …